Renee D. Gala - 08 May 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Renee D. Gala
Issuer symbol
DXCM
Transactions as of
08 May 2025
Net transactions value
$0
Form type
4
Filing time
12 May 2025, 16:09:05 UTC
Previous filing
10 Mar 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GALA RENEE D Director 6340 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Renee D. Gala 12 May 2025 0001607737
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +5,074 +89% $0.000000 10,794 08 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Included in this number are 10,794 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 5,074 of which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.